Christopher P. Smith

Christopher P. Smith, M.D., M.B.A., Associate Professor, is a Board-certified urologist specializing in male and female urinary incontinence and voiding dysfunction. Dr. Smith attended Northwestern University Medical School in Chicago and received his residency training in urology at Baylor College of Medicine. He completed his fellowship training under a National Institutes of Health (NIH) K12 Scholarship in Neurology and Female Urology at the University of Pittsburgh School of Medicine in Pennsylvania. He received his M.B.A. at the Katz School of Business, University of Pittsburgh.

Dr. Smith is currently a Lieutenant Colonel in United States Army Reserve Corps and has been deployed three times in support of Operation Enduring Freedom (OEF).

Dr. Smith was awarded the Paul Zimskind Award in 2006 by the Society for Urodynamics and Female Urology for continuing excellence and leadership in the field of voiding dysfunction. He was recently awarded a three-year Career Development Award by the Department of Veterans Affairs to study the role of spinal purinergic pathways in the development of bladder overactivity. In addition, he has been honored with the Astellas Rising Star in Urology Award by the American Urological Association Foundation for three years to support his career development research. Dr. Smith received 2nd Prize in the prestigious Jack Lapides Essay Contest for a research paper in 2008 investigating the effects of botulinum toxin A in spinal cord injured bladders, as well as the Apple Award from the American Spinal Injury Association. He has also been listed in Castle Connolly's America's Top Doctors.

Dr. Smith has published numerous articles in scientific journals, including over 50 peer-reviewed papers and many invited articles to other publications. An active academician and speaker, he has presented many papers at scientific meetings and has served as guest lecturer across the country.

Dr. Smith is an international expert on the basic and clinical aspects of botulinum toxin use within urology. He has used botulinum toxin clinically for over a decade. In addition to his extensive involvement in basic science research, Dr. Smith is a principal investigator on several clinical trials examining the effects of botulinum toxin to treat patients with overactive bladder and benign prostatic hyperplasia (BPH).